Skip to main content
Category

News Archive

listen-conversation-pixa

Listening Is a Lost Art in Medicine. Here’s How to Rediscover It

By News Archive

listen-conversation-pixa

William Osler, often called the father of modern medicine, famously advised his students: “Just listen to your patient; he is telling you the diagnosis.” A century later, clinicians and health system leaders started tuning out the patient’s voice, turning instead to electronic health records and the latest care protocols to manage their most complicated and high-need patients. We believe it’s time for an urgent and strategic reset. The factors that lead people to become our nation’s costliest are complex. But they call for, at the start, the simplest intervention: listening.

Read More
eli-lilly-logo

Innovating at the speed of the 21st century in pharmaceuticals | McKinsey & Company

By News Archive

eli-lilly-logo

Eli Lilly and Company is an innovation-driven biopharmaceutical company that aspires to make a significant contribution to humanity by improving global health in the 21st century. In this article, part of our Biopharma Frontiers series on how the pharmaceutical industry is evolving and how leaders can adapt, David A. Ricks, the chairman and CEO of Eli Lilly, discusses the opportunities and rewards for innovation and the implications for industry business models. This article is an edited summary of his conversation with McKinsey.

Read More
umb-johns-hopkins-logo

Why UMB and Hopkins came together to grow entrepreneurship in Maryland – Baltimore Business Journal

By News Archive

umb-johns-hopkins-logo

University of Maryland, Baltimore and Johns Hopkins University could safely be classified as “friendly competitors.” Operating in the same city, the two institutions “compete” for the funding and recognition as major research forces in the state. Both are affiliated with large medical systems, anchored by two of the highest-earning hospitals in the state.

Read More
umd-ibbr-0608-logo

IBBR and Frederick National Lab Establish a Human Papillomavirus (HPV) Vaccine Development Collaboration – Institute for Bioscience and Biotechnology Research

By News Archive

umd-ibbr-0608-logo

University of Maryland’s Institute for Bioscience and Biotechnology Research (IBBR) will work under a formal collaboration with the Frederick National Laboratory for Cancer Research (operated by Leidos Biomedical Research, Inc.) to explore new candidate vaccines against human papillomavirus (HPV), a common cause of cervical cancer.

Read More
regenerative-medicine-xray-tech-pixa

Precision medicine: How an evolving definition has helped advance clinical accuracy – MedCity News

By News Archive

regenerative-medicine-xray-tech-pixa

“Precision medicine gives us the chance to marry what’s unique about America – our spirit of innovation, our courage to take risks, our collaborative instincts – with what’s unique about Americans – every individual’s distinctive genetic makeup, lifestyles, and health needs. In doing so, we can keep ourselves, our families, and our nation healthier for generations to come.”

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.